Ion channel modulating compounds and uses thereof
Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.
1. A compound having the following structure:
as an isolated enantiomeric or diastereomeric isomer or as a mixture thereof, or as a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 wherein the compound is a mixture of isomers.
3. The compound of claim 2 wherein the compound has the following structure:
or pharmaceutically acceptable salt thereof.
4. The compound of claim 2 wherein the compound has the following structure:
or pharmaceutically acceptable salt thereof.
5. The compound of claim 1 wherein the compound is an isolated isomer.
6. The compound of claim 5 wherein the compound has the following structure:
or pharmaceutically acceptable salt thereof.
7. The compound of claim 5 wherein the compound has the following structure:
or pharmaceutically acceptable salt thereof.
8. The compound of claim 5 wherein the compound has the following structure:
or pharmaceutically acceptable salt thereof.
9. The compound of claim 5 wherein the compound has the following structure:
or pharmaceutically acceptable salt thereof.
10. A composition comprising a compound of any one of claims 1 – 9 , in combination with a pharmaceutically acceptable carrier, excipient or diluent.